Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade

Oncoscience. 2017 Sep 20;4(7-8):67-69. doi: 10.18632/oncoscience.359. eCollection 2017 Jul.

Authors

Dipongkor Saha¹, Robert L Martuza¹, Samuel D Rabkin¹

Affiliation

¹ Molecular Neurosurgery Laboratory and the Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

No abstract available

Keywords: cancer stem cells; herpes simplex virus; immune checkpoint; immunotherapy; oncolytic virus.

Publication types

Editorial